Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study 203120: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Plaque Psoriasis

NCT02564042 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT02564042
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02564042 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study 203120: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Plaque Psoriasis
Lead sponsor
GlaxoSmithKline
Phase
Phase 2
Overall status
Completed
Start date
November 23, 2015
Completion date
October 5, 2016
Enrollment
227 (actual)
Sites
46

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis